Pepro Tech

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werz, O.
Right arrow Articles by Samuelsson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werz, O.
Right arrow Articles by Samuelsson, B.
(Journal of Leukocyte Biology. 2001;70:830-838.)
© 2001 by Society for Leukocyte Biology

p38 MAP kinase mediates stress-induced leukotriene synthesis in a human B-lymphocyte cell line

Oliver Werz, Jenny Klemm, Olof Rådmark and Bengt Samuelsson

Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institute, Stockholm, Sweden

Correspondence: Dr. Olof Rådmark, Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institute, S-171 77 Stockholm, Sweden. E-mail: olof.radmark{at}mbb.ki.se


arrow
ABSTRACT
 
5-Lipoxygenase (5-LO), which catalyzes the first two steps in leukotriene biosynthesis, is a target for pharmacological treatment of inflammatory disorders. Previous studies have shown that B-lymphocytes express 5-LO. Here we demonstrate that several stimuli of cell stress such as osmotic shock (sorbitol, NaCl), oxidative stress (hydrogen peroxide, diamide), chemical stress sodium arsenite, and inflammatory cytokines enhanced cellular 5-LO activity in a B cell line (BL41-E95-A), when added simultaneously with ionophore plus arachidonate. It is interesting that sorbitol alone was sufficient for 5-LO product formation in the presence of exogenous arachidonic acid. These stimuli also activated p38 mitogen-activated protein (MAP) kinase and downstream MAP kinase-activated protein kinases in BL41-E95-A cells, which could phosphorylate 5-LO or heat shock protein 27 in vitro. The p38 MAP kinase inhibitor SB203580 abolished stress-induced leukotriene synthesis in B cells, without inhibition of 5-LO catalytic activity in cell-free systems. Our results indicate that p38 MAP kinase activation by cell stress is required for efficient leukotriene synthesis in B-lymphocytes.

Key Words: 5-lipoxygenase • mitogen-activated protein kinase • heat shock protein • Mono Mac 6 • hypertonicity • sodium arsenite


arrow
INTRODUCTION
 
Leukotrienes (LTs) are lipid mediators with important roles in inflammatory and allergic diseases [1 ]. 5-Lipoxygenase (5-LO), which catalyzes the two initial steps in LT biosynthesis, is expressed in polymorphonuclear leukocytes (PMNLs), monocytes/macrophages, mast cells, dendritic cells, and B-lymphocytes. On cell activation, 5-LO can translocate from a soluble cell compartment to the nuclear envelope, leading to colocalization with cytosolic phospholipase A2 (cPLA;I2) and 5-LO-activating protein (FLAP). In intact cells, full 5-LO activity requires the presence of FLAP and is further regulated by the cellular redox status. A putative N-terminal C2-like domain in 5-LO mediates Ca2+ activation of 5-LO activity [2 ] and is essential for association of 5-LO with the nuclear membrane [3; for review of 5-LO, see ref. 4 5 ].

The three major mitogen-activated protein (MAP) kinase (MAPK) families, the extracellular signal-regulated kinases (ERKs), the c-jun NH2-terminal kinases/stress activated protein kinases (JNKs/SAPKs), and the p38 MAPKs are protein serine/threonine kinases that require dual phosphorylation on tyrosine and threonine residues for activity [6 ]. In contrast to the ERKs, which are mainly activated by growth factors and other mitogenic stimuli, JNKs and p38 MAPKs are activated in response to a number of stress stimuli. In mammalian cells, p38 MAPK is activated by oxidative stress, hyperosmolarity, UV light, heat shock, sodium arsenite (SA), endotoxin, and inflammatory cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-{alpha} [7 ]. The activated kinase phosphorylates downstream MAPK-activated protein (MAPKAP) kinases and certain transcription factors [8 9 10 11 ]. SB203580, at concentrations below 10 µM, has been demonstrated to be an inhibitor of p38 MAPK with no or minor effects on JNK, ERK, and several other protein kinases [12 ] and is thus considered a useful tool to evaluate p38 MAPK-dependent events in vivo. Recently we showed that p38 MAPK-regulated MKs can phosphorylate 5-LO in vitro and that up-regulation of MK activity in PMNLs is connected with increased 5-LO activity [13 ]. Tyrosine kinase signaling also is important for LT synthesis and translocation of 5-LO to the nuclear membrane in granulocytic cells, and it has been demonstrated that 5-LO can occur in a phosphorylated form after stimulation of HL60 cells with ionophore [14 ]. p38 MAPK is also involved in the phosphorylation and activation of cPLA2, which releases arachidonic acid (AA) as substrate for LTs and prostaglandins [15 ], and stimuli of cell stress (H2O2, SA, sorbitol) enhanced ionophore-induced AA release in platelets [16 ].

In addition to well-established functions of LTs as inflammatory mediators, several findings imply that LTs also are involved in the primary adaptive immune response. Thus, LTB4 enhanced both lymphokine-driven proliferation of B lymphocytes [17 ] and IL-4-induced immunoglobulin (Ig) E production in normal peripheral blood mononuclear cells [18 ]. In mice subjected to targeted 5-LO gene disruption, ovalbumin-induced IgG and IgE production is reduced [19 ]. Also, 5-LO is expressed in dendritic cells [20 , 21 ], and mobilization of dendritic cells to lymph nodes depends on the LTC4 transporter multidrug resistance protein 1 [22 ]. B-lymphocytes express 5-LO protein and produce 5-LO metabolites in cell homogenates, but in contrast to PMNLs or monocytes, cellular 5-LO activity in BL41-E95-A cells is suppressed by selenium-dependent peroxidases [23 , 24 ]. However, LT synthesis in B cells is strongly enhanced after increase in the cellular redox status, via depletion of glutathione or by addition of hydrogen peroxide or hydroperoxides [23 , 25 , 26 ]. Oxidative stress (exposure to H2O2, diamide, or ionizing irradiation) is reported to trigger tyrosine phosphorylation and MAPK activation in B-lymphocytes, resulting in cell activation [27 28 29 30 31 ]. In B-lymphocytes, p38 MAPK is required for CD40-induced gene expression and proliferation [32 ] and IgM-induced apoptosis [33 ]. Here we demonstrate that stimuli of cellular stress up-regulate LT synthesis in BL41-E95-A cells and that stress-induced 5-LO activity is blocked by the p38 MAPK inhibitor SB203580. Cellular stress also led to increased activation of p38 MAPK and phosphorylation of MAPKAP kinase (MK) substrates in vitro (5-LO and Hsp27), which coincided with LT synthesis.


arrow
MATERIALS AND METHODS
 
Materials and sources
The following materials were used: RPMI 1640 medium (Life Technologies, Grand Island, NY; high-performance liquid chromatography (HPLC) solvents, (Rathburn Chemicals, Walkerburn, Scotland); hydrogen peroxide (Perhydrol; Merck, Darmstadt, Germany); diamide, fetal calf serum, recombinant Hsp27, phenylarsine oxide, SA, sodium orthovanadate, and sorbitol (Sigma, St. Louis, MO); SB203580 (Calbiochem, Nottingham, United Kingdom); antibodies against dually phosphorylated p38 MAPK (New England Biolabs, Inc., Frankfurt, Germany), and p38 MAPK (C-20) and MAPKAP kinase-2 (C-18) (Santa Cruz Biotechnology, Santa Cruz, CA). Human recombinant 5-LO was expressed and purified as previously described [34 ]. [{gamma}-32P]ATP (110 TBq/mmol) was purchased from Amersham-Pharmacia, Uppsala, Sweden. Human transforming growth factor (TGF)-ß1 was purified from outdated platelets as previously described [35 ], and calcitriol was obtained from Biomol, Plymouth Meeting, PA.

Cells and cell culture
BL41-E95-A cells were kindly provided by Dr. H.-E. Claesson (Karolinska Institute, Stockholm) and maintained in RPMI 1640 medium with glutamine supplemented with 10% fetal calf serum, 100 µg/mL of streptomycin, and 100 U/mL of penicillin. Cultures were seeded at a density of 2 x 105 cells/mL. Monocyte-macrophage 6 (MM6) cells were cultured and differentiated with TGF-ß and calcitriol as previously described [36 ]. Cells were harvested by centrifugation [200 g, 10 min, room temperature (RT)], washed once in phosphate-buffered saline (PBS), pH 7.4, and finally resuspended in PBS containing 1 mM Ca2+ and 1 mg/mL of glucose.


arrow
Determination of 5-LO activity
 
For intact cells, BL41-E95-A cells (1.5 x 107 in 1 mL of PBS with 1 mM Ca2+ and 1 mg/mL of glucose) were preincubated as indicated. The 5-LO reaction was started by addition of the indicated additives together with AA and ionophore A23187 at the indicated concentrations. After 10 min at 37°C, the reaction was stopped with 1 mL of methanol and 30 µL of 1 N HCl, and 200 ng of prostaglandin B1 (internal standard) and 500 µL of PBS were added. After centrifugation (10 min, 800 g) the samples were applied to C-18 solid-phase extraction columns (100 mg) which were conditioned with 1 mL of methanol and 1 mL of water. The columns were washed with 1 mL of water and 1 mL of 25% methanol. 5-LO metabolites were extracted with 300 µL of methanol. The extract was diluted with 120 µL of water, and a 100-µL aliquot of the diluted extract was analyzed by high-performance liquid chromatography (HPLC) as previously described [37 ], using a C-18 Radial-Pak column (Waters, Eschborn, Germany) eluted with methanol-water-acetic acid 75:25:0.1 (v/v/v) at a flow rate of 1.2 mL/min. Determination of amounts formed of different metabolites was performed by peak area integration. 5-LO activity is expressed as picomoles of 5-LO products per 106 cells, which includes LTB4, the all-trans isomers of LTB4, and 5(S)-hydro(peroxy)-6-trans-8,11,14-cis-eicosatetraenoic acid. To determine the effects of SB203580 on catalytic activity of crude 5-LO, homogenates of BL41-E95-A cells were prepared by sonication (three times on ice for 5 s each time) and preincubated with SB203580 for 10 min at 4°C, and 5-LO activity was assayed as previously described [24 ]. To study the activity of isolated 5-LO, the enzyme was expressed in Escherichia coli and purified and assayed as described elsewhere [34 , 38 ]. 5-LO (0.2 µg) was preincubated with the indicated concentrations of SB203580 for 10 min before the 5-LO reaction was started.

Western blot
For preparation of total cell lysates, cells were resuspended in PBS with 1 mM Ca2+ and 1 mg/mL of glucose, lysed by addition of the same volume of 2x sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) sample loading buffer [SDS-b; 20 mM Tris/HCl, pH 8, 2 mM EDTA, 5% SDS (w/v), 10% ß-mercaptoethanol], vortexed, and heated at 95°C for 6 min. Aliquots of cell lysates or subcellular fractions were analyzed by SDS-PAGE on a 4–15% linear gradient gel. After electroblotting to nitrocellulose membrane (Hybond C; Amersham-Pharmacia), membranes were blocked with 5% nonfat dry milk in Tris-buffered saline (TBS; 50 mM Tris/HCl, pH 7.4, and 100 mM NaCl) for 1 h at RT. Membranes were washed and then incubated with antisera overnight at 4°C. The membranes were washed with TBS and incubated with a 1:1,000 dilution of alkaline phosphatase (AP)-conjugated IgGs (Sigma) for 2 h at RT. After washing with TBS and TBS plus 0.1% Nonidet P-40 (NP-40), proteins were visualized with the AP substrates nitro blue tetrazolium and 5-bromo-4-chloro-3-indolylphosphate (Sigma) in detection buffer (100 mM Tris/HCl, pH 9.5, 100 mM NaCl, 5 mM MgCl2).

In vitro kinase assay
For preparation of samples, incubations were stopped by addition of 2 v of ice-cold lysis buffer (20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.5 % NP-40, 50 mM NaF, 2 mM Na3VO4, 25 mM ß-glycerophosphate, 10 mM sodium pyrophosphate, 10 mM 4-nitrophenyl phosphate, 1 mM phenylmethylsulfonyl fluoride, 5 µM ZnCl2, 10 µg/mL of leupeptin, and 60 µg/mL of soybean trypsin inhibitor). During 10 min in this buffer, the suspension was vortexed repeatedly (5-s bursts) to assure complete lysis. Supernatants were obtained by centrifugation of the lysates (16,000 g, 10 min, 4°C) and kept on ice. Aliquots corresponding to 0.2 x 106 BL41-E95-A cells were immediately mixed with the same volume of kinase buffer (25 mM HEPES, pH 7.5, 25 mM MgCl2, 25 mM ß-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4) containing ATP (50 µM) and [{gamma}-32P]ATP (2 µCi/mL), and 1 µg of recombinant Hsp27 was added as substrate. The final volume was 20 µL, and incubation time was 30 min at 30°C. The reaction was terminated by addition of SDS-b and heating at 95°C for 6 min. Samples were separated by SDS-PAGE (see Western blot), and phosphorylated proteins were visualized by autoradiography of the dried gels.

In-gel kinase assay
Incubations were stopped by addition of the same volume of SDS-b and heating for 6 min at 95°C. Total cell lysates of BL41-E95-A cells and MM6 cells corresponding to 0.5 x 106 cells were analyzed for 5-LO kinase activity by in-gel kinase assay using purified 5-LO (0.2 mg/mL) as substrate as described [13 ].

Subcellular fractionation by detergent lysis
Subcellular localization of 5-LO was investigated as described previously [39 ]. In brief, BL41-E95-A cells (3 x 107) or MM6 cells (1 x 107) were resuspended in 1 mL of PBS with 1 mM Ca2+ and 1 mg/mL glucose. After addition of the indicated stimuli, samples were incubated for 5 min at 37°C and chilled on ice. Nuclear and non-nuclear fractions were obtained after cell lysis by 0.1% NP-40. Aliquots of nuclear and non-nuclear fractions were immediately mixed with the same volume SDS-b, heated for 6 min at 95°C, and analyzed for 5-LO protein by Western blot using affinity purified 5-LO antiserum 1551.


arrow
RESULTS
 
Cellular stress induces 5-LO activity in intact BL41-E95-A cells
Previously, it was found that stimulation of BL41-E95-A cells with 10 µM ionophore plus 40 µM AA caused only marginal cellular 5-LO activity [23 , 24 ], which was strongly increased when cells had been exposed to oxidative stress [23 , 25 , 26 ]. We present here that LT synthesis in BL41-E95-A cells was increased also by other forms of cell stress. As shown in Figure 1A , osmotic shock with NaCl (0.1–0.4 M) or sorbitol (0.4–1 M) up-regulated 5-LO activity up to 5-fold compared with control incubations which received only ionophore plus AA. Similar effects were found with KCl (0.1–0.5 M) (data not shown). Treatment of BL41-E95-A cells with SA (0.1–1 mM), which mimics heat shock, gave a similar increase in 5-LO product formation. Finally, the inflammatory cytokines TNF-{alpha} and IL-1 (added together with A23187 plus AA), also enhanced cellular 5-LO activity. As observed for PMNL and MM6 cells stimulated with ionophore plus exogenous AA, 5-HETE was always the major 5-LO metabolite (~75–80 %) released from BL41-E95-A cells, and no agonist dependent shift in the ratio of 5-HETE, LTB4 and its all-trans isomers was observed. As found by others [23 , 26 ] 5-LO activity in BL41-E95-A cells depended on the presence of exogenous substrate, and maximal 5-LO product formation was obtained at 40 µM AA. Cell stress (0.8 M sorbitol, 1 mM SA) induced upregulation of 5-LO activity was similar (about fivefold) also at 2.5, 10 or 20 µM AA (data not shown). 5-LO product formation also correlated to the concentration of ionophore used, at 1 µM A23187 5-LO product formation was about 30–50%, compared with 10 µM ionophore. Osmotic stress (0.8 M sorbitol) upregulated 5-LO activity to the same extent (four- to fivefold) also at 1 µM ionophore. Treatment of BL41-E95-A cells with stress stimuli (1 mM SA, 0.3 M NaCl or 0.8 M sorbitol) did not affect the integrity of the cells as determined by light microscopy with trypan blue exclusion (not shown), indicating that 5-LO product formation occurred in intact cells and was not due to crude catalytic activity of 5-LO in broken cell preparations.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Cellular stress stimulates 5-LO activity in BL41-E95-A cells. BL41-E95-A cells (1.5 x 107 in 1 mL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2) were incubated for 10 min at 37°C with the indicated stimuli, and 5-LO activity was determined by HPLC as described in Material and Methods. (A) All incubations received 10 µM ionophore A23187 plus 40 µM AA (control conditions). In addition, sorbitol, SA (at the indicated concentrations), and 1 ng/mL of TNF-{alpha} and IL-1, respectively, were added as indicated. (B) Cells were stimulated with 40 µM AA or with 40 µM AA plus 1 µM thapsigargin (thaps), in the presence or absence of 0.8 M sorbitol. Results are given as mean ± SE; n = 3–4.

As can be seen from Figure 1B 1a four- to fivefold increase in 5-LO product formation by sorbitol (0.8 M), was also observed when cells were stimulated with thapsigargin plus AA. Of considerable interest, we found that in presence of exogenous AA, addition of sorbitol alone (no ionophore) was sufficient to induce 5-LO product formation (Fig. 1B) , indicating that calcium-mobilizing agents are not absolutely necessary for 5-LO product synthesis. Again, 5-HETE was the major 5-LO product formed (about 80% of total products).

The effects of cellular stress were prominent, when cells were stimulated simultaneously with stress-inducers and ionophore plus AA and were less prominent with longer preincubation periods. The time-course of the effect of osmotic stress on 5-LO product formation is shown in Figure 2 . BL41-E95-A cells were treated with 0.3 M NaCl for 0–10 min before the addition of ionophore plus AA, and 5-LO activity was determined. Addition of NaCl together with ionophore gave the best effect, about fivefold activation. Repeated addition of NaCl (10 min after the first addition) gave no activation, however transfer of cells which had been treated with NaCl for 10 min to fresh buffer, and renewed stimulation with 0.3 M NaCl restored the up-regulative effect (Fig. 2) , again indicating that hyperosmolarity did not compromise cell integrity.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Time-course of osmotic stress-induced 5-LO activity. BL41-E95-A cells (1.5 x 107 in PBS containing 1 mg/mL of glucose and 1 mM CaCl2) were preincubated with 0.3 M NaCl at 37°C for the indicated times and subsequently stimulated with ionophore A23187 and AA (10 and 40 µM, respectively) for another 10 min. Alternatively, cells were washed after NaCl treatment by centrifugation (500 g, 3 min, RT), resuspended in fresh buffer, and stimulated with 0.3 M NaCl together with A23187 plus AA (10 and 40 µM, respectively). 5-LO activity was determined by HPLC. Results are expressed as means + SE of three independent experiments.

Protein tyrosine phosphatase inhibitors upregulate cellular 5-LO activity in BL41-E95-A cells
Oxidative stress upregulates tyrosine phosphorylation via inhibition of protein tyrosine phosphatases [28 29 30 31 , 40 ], and tyrosine kinase signalling was connected to 5-LO activation in leukocytes [14 ]. Since oxidative stress stimulates cellular LT synthesis in B-lymphocytes [25 ] we examined the association between 5-LO activity and increased tyrosine phosphorylation. Thus, protein tyrosine phosphatase inhibitors were tested for their ability to stimulate 5-LO activity in BL41-E95-A cells. As shown in Table 1 , simultaneous addition of H2O2 (10 µM) together with ionophore and AA (10 and 40 µM, respectively), leads to a fivefold upregulation of 5-LO activity, versus control without H2O2. It is interesting that the tyrosine phosphatase inhibitors sodium orthovanadate (100 µM), phenylarsine oxide (PAO, 1 µM) or diamide (100 µM), added together with ionophore plus AA also enhanced cellular 5-LO product formation, comparable to H2O2. Preincubation with H2O2 or the phosphatase inhibitors (diamide, sodium orthovanadate and PAO) for >3–5 min resulted in less prominent activation of 5-LO, and presence of these compounds in broken cell preparations had no effect on 5-LO catalytic activity (data not shown). The data suggest that increased tyrosine phosphorylation activates 5-LO in BL41-E95-A cells. The finding that preincubation with H2O2 led to decreased 5-LO activity can be explained, because H2O2 can inactivate 5-LO by reacting with ferrous iron in the 5-LO active site [41 ]. Possibly, phosphatase inhibitors with oxidant properties could lead to similar effects.


View this table:
[in this window]
[in a new window]
 
Table 1. 5-LO Activity in BL41-E95-A Cells

Activation of p38 MAPK and MKs, phosphorylation of 5-LO
Recently we could show that stimulation of PMNL or MM6 cells led to activation of p38 MAPK-regulated MKs, which could phosphorylate 5-LO in vitro [13 ]. Western blots in Figure 3A illustrate that both p38 MAPK and MK2 are expressed in BL41-E95-A cells, compared with MM6 cells. Activation of MKs was examined by in vitro kinase assay using Hsp27, a major and well-characterized substrate for MK2 [42 ]. BL41-E95-A cells were preincubated pairwise in the presence or absence of the p38 MAPK inhibitor SB203580 (10 µM) and incubated with various stress stimuli for 2.5 min. Total cell lysates were prepared and mixed with the same volume of kinase buffer, and kinase activity towards Hsp27 was determined. As shown in Figure 3B , stimulation with ionophore (10 µM) caused no increase in kinase activity compared with activity in untreated control cells. However, stress-stimuli such as sorbitol, SA, NaCl, and H2O2, as well as the protein tyrosine phosphatase inhibitor diamide, led to increased Hsp27 phosphorylation. In all cases, kinase activity was strongly reduced in the presence of 10 µM SB203580.



View larger version (47K):
[in this window]
[in a new window]
 
Figure 3. Expression and activity of p38 MAPK and MKs. (A) Expression of p38 MAPK and MK2 in MM6 cells (lanes 1 and 3) and BL41-E95-A cells (lanes 2 and 4). Total cell lysates corresponding to equal amounts of cells (0.5 x 106) were analyzed by Western blot using antibodies against p38 MAPK and MK2. (B) In vitro kinase assay with Hsp27 as substrate. BL41-E95-A cells (5 x 106 in 1 mL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2) were preincubated pairwise with or without 10 µM SB203580 for 30 min at 37°C. Two and one-half minutes after addition of the indicated stimuli at 37°C, cells were lysed and supernatants were assayed for MK activity. Concentrations: Ionophore, 10 µM; sorbitol, 0.8 M; SA, 1 mM; H2O2, 10 µM; NaCl, 0.3 M; and diamide, 100 µM. Phosphorylated Hsp27 was separated by SDS-PAGE and visualized by autoradiography. (C) Determination of 5-LO kinase activity in total cell extracts of MM6 and BL41-E95-A cells. Cells (2.5 x 107 in 1 mL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2) were incubated at 37°C with the indicated additives (ionophore, 10 µM; sorbitol, 0.8 M; SB203580, 3 µM). After 3 min, cells were lysed by addition of SDS-b, vortexed, and heated at 95°C for 6 min. Aliquots corresponding to 0.5 x 106 cells were analyzed for 5-LO kinase activity in a SDS-10% polyacrylamide gel, which was polymerized in the presence of 0.2 mg/mL of purified recombinant 5-LO as described in Materials and Methods. Positions of standard proteins are indicated. Similar results were obtained in two additional independent experiments.

Activation of MKs with 5-LO as substrate was studied using in-gel kinase assays. BL41-E95-A cells and, for comparison, MM6 cells were stimulated for 3 min as indicated, and total cell lysates were subjected to in-gel kinase assays using 5-LO as substrate. In agreement with previous studies, treatment of MM6 cells with ionophore for 3 min resulted in activation of 5-LO kinases at 42, 47, and 55 kDa (Fig. 3C , left panel), which we have suggested to be MK2 and MK3 [13 ]. In contrast to MM6 cells, stimulation of BL41-E95-A with ionophore alone did not give enhanced 5-LO kinase activity; however, simultaneous addition of sorbitol (3 min) led to activation of 5-LO kinases at 47 and 55 kDa (Fig. 3C , right panel). Similar results were obtained when thapsigargin was used instead of ionophore (data not shown). When cells were lysed after a 10-min incubation, the 47-kDa band was not observed, indicating that MK activation was transient (data not shown). When the same lysates were analyzed in in-gel kinase assays without 5-LO as substrate, the 47-kDa band was absent, and only a weak band appeared at 55 kDa, indicating that autophosphorylation of the kinases was negligible (data not shown). Based on migration properties and sensitivity against SB203580, we suggest that the kinase at 47 kDa is MK2 [compare ref. 13 ]. The band at 55 kDa was rather strong and less sensitive to the p38 MAPK inhibitor, which could indicate that this band was caused by other kinase activities. When MM6 cells were treated with both ionophore and sorbitol, no further kinase activation was observed (data not shown).

Activation of p38 MAPK was demonstrated by Western blot analysis of BL41-E95-A cell lysates with an antibody recognizing the dually phosphorylated kinase. As shown in Figure 4A , relatively small amounts of phosphorylated (activated) p38 MAPK were present in unstimulated BL41-E95-A cells, and treatment with 10 µM ionophore and/or 40 µM AA caused no significant p38 MAPK activation, whereas addition of sorbitol led to a strongly increased signal. Activation of p38 MAPK was not dependent on the presence of ionophore and AA; treatment of BL41-E95-A cells with sorbitol or SA alone was sufficient for kinase activation (data not shown). The time courses for activation of p38 MAPK and 5-LO were compared. For cells stimulated with sorbitol, ionophore, and AA, both p38 MAPK phosphorylation (Fig. 4B) and 5-LO products were maximal after 2 min (Fig. 4C) .



View larger version (26K):
[in this window]
[in a new window]
 
Figure 4. Activation of p38 MAPK correlates to 5-LO activity. (A) Activation of p38 MAPK. BL41-E95-A cells (1.5 x 107) resuspended in 100 µL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2 were stimulated at 37°C without or with ionophore (10 µM), AA (40 µM), and sorbitol (0.8 M) as indicated. After 2.5 min, incubations were terminated by addition of the same volume of SDS-b, and total cell lysates were analyzed by SDS-PAGE and immunoblotting using a specific antibody that detects the dually phosphorylated form of p38 MAPK (upper panel). Equal sample loading was demonstrated with anti-p38 MAPK antibody (lower panel). (B) Time-course of p38 MAPK activation. BL41-E95-A cells (1.5 x 107) resuspended in 100 µL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2 were stimulated at 37°C with 0.8 M sorbitol as indicated. All incubations received 10 µM A23187 plus 40 µM AA simultaneously with sorbitol. After the indicated times, incubations were terminated by addition of the same volume of SDS-b, and samples were analyzed for phosphorylated p38 MAPK and p38 MAPK. (C) Time-course of 5-LO product formation. BL41-E95-A cells (1.5 x 108 in 10 mL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2) were stimulated with 0.8 M sorbitol plus ionophore A23187 and AA (10 and 40 µM, respectively). After the indicated times at 37°C, aliquots (1 mL, corresponding to 1.5 x 107 cells) were mixed with 1 mL of methanol. 5-LO activity was determined as described in the Materials and Methods section.

Stress-induced 5-LO activity is inhibited by SB203580
SB203580 was used to study the involvement of p38 MAPK in stress-induced LT synthesis. BL41-E95-A cells were preincubated with SB203580 and stimulated with NaCl or H2O2 (together with ionophore and AA), and 5-LO activity was determined. As shown in Figure 5 , 5-LO activity in intact BL41-E95-A cells was dose dependently inhibited by SB203580, with a 50% inhibitory concentration of 3–5 µM. In broken cell preparations, the compound did not affect crude 5-LO activity up to 30 µM (Fig. 5) , and the 50% inhibitory concentration or purified recombinant 5-LO was >100 µM (data not shown).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 5. Effects of SB203580 on 5-LO activity in BL41-E95-A cells. Intact BL41-E95-A cells (1.5 x 107 in PBS containing 1 mg/mL of glucose and 1 mM CaCl2), or corresponding homogenates were preincubated with the indicated concentrations of SB203580 for 30 min at 37°C (intact cells) or 10 min at 4°C (homogenates). To intact cells, H2O2 (10 µM) or NaCl (0.3 M) was added together with ionophore A23187 and AA (10 and 40 µM, respectively). To homogenates, 1 mM ATP was added, and the 5-LO reaction was started by addition of CaCl2 and AA (1 and 40 µM, respectively). After 10-min incubations at 37°C, 5-LO activity was determined as described in Materials and Methods. Results are expressed as means ± SE of three independent experiments.

Subcellular localization of 5-LO
The localization of 5-LO in resting and activated BL41-E95-A and MM6 cells was determined by Western blot of subcellular fractions prepared after mild detergent lysis (0.1 % NP-40). As reported previously [39 ], 5-LO in resting MM6 cells is found exclusively in the nonnuclear fraction (cytosol) and is associated with the nucleus on priming with phorbol myristate acetate and stimulation with ionophore (Fig. 6 , left panel); this translocation is accompanied by substantial 5-LO product formation [39 ]. In resting BL41-E95-A cells, 5-LO was also localized in a nonnuclear compartment. However, cell stimulation that led to 5-LO product formation (sorbitol plus ionophore plus AA) caused no association of 5-LO with the nucleus. After NP-40 lysis of BL41-E95-A cells, intact nuclei could be observed by light microscopy.



View larger version (51K):
[in this window]
[in a new window]
 
Figure 6. Subcellular distribution of 5-LO. For determination of 5-LO distribution in resting and activated cells, 1 x 107 MM6 cells and 3 x 107 BL41-E95A cells were resuspended in 1 mL of PBS containing 1 mg/mL of glucose and 1 mM CaCl2 and incubated with or without activators for 5 min at 37°C. For activation, MM6 cells were incubated with 100 nM PMA at 37°C for 10 min before the addition of 5 µM ionophore (5 min). BL41-E95-A cells were treated with 10 µM ionophore, 40 µM AA, and 0.8 M sorbitol for 5 min. Cell fractionation and 5-LO Western blotting were performed as described in experimental procedures. Pairwise samples (nonnuclear and nuclear) correspond to the identical cell numbers.

Taken together, the results indicate that (1) in contrast to MM6 cells (or PMNLs [13 ]), stimulation of BL41-E95-A cells with ionophore is not sufficient to activate p38-dependent MKs for phosphorylation of 5-LO, (2) sorbitol or other stress inducers are required for high p38 MAPK/MK2 activity in BL41-E95-A cells, and (3) p38 MAPK/MK2 activation correlates with cellular 5-LO activity in BL41-E95-A cells.


arrow
DISCUSSION
 
B-lymphocytes express 5-LO, and considerable amounts of LTs are formed in broken-cell preparations [43 ]. In contrast to human PMNLs and monocytes/macrophages, cellular 5-LO activity in B cells is strongly suppressed by selenium-dependent peroxidases [24 ]. However, conditions that lead to oxidative stress, such as depletion of glutathione peroxidases [24 ]; coaddition of hydrogen peroxide, hydroperoxides [25 ], or thiol reactive agents (diamide, 1-chloro-2,4-dinitrobenzene, or N-ethylmaleimide) [23 , 26 ]; and coincubation with superoxide-releasing PMNLs [25 ], lead to activation of 5-LO and subsequent formation of LTs in these cells. It has been assumed that pro-oxidizing agents stimulate 5-LO by promoting formation of ferric iron in the lipoxygenase-active site.

Expression and functionality of p38 MAPK and MK2 in B-lymphocytes have been reported [44 ]. For example, p38 MAPK is involved in the mouse IgM-induced apoptosis of human B cells [33 ] and in CD40-induced gene expression and proliferation [32 ]. Oxidative stress has been shown to trigger protein tyrosine phosphorylation and MAPK activation in B-lymphocytes [27 ]. Oxidants such as H2O2, diamide, and phenylarsine oxide increase tyrosine phosphorylation via inhibition of protein tyrosine phosphatases [28 29 30 31 , 40 ]. Activation of p38 MAPK involves dual phosphorylation on both Thr and Tyr in the TGY motif [7 ], and many of the kinases in the cascade upstream of p38 MAPK are tyrosine kinases; thus it appears reasonable that p38 MAPK in BL41-E95-A cells could be sensitive to the redox state of the cells, via the regulation of tyrosine kinase activity. Recently, we established that 5-LO is phosphorylated by p38 MAPK-dependent MKs, and we suggested that this phosphorylation might regulate cellular 5-LO activity [13 ]. Because low cellular 5-LO activity in B cells can be enhanced by oxidative stress, we investigated the involvement of p38 MAPK in this process.

We found that cellular stress (hyperosmolarity, SA, and oxidative stress), protein tyrosine phosphatase inhibitors, or cytokines TNF-{alpha} plus IL-1 up-regulate ionophore-induced LT synthesis in the human B cell line BL41-E95-A. Cell stress as well as the proinflammatory cytokines TNF and IL-1 are potent activators of p38 MAPK [7 ] and have been shown to activate MKs in various leukocytes capable of phosphorylating 5-LO in vitro [13 ]. Activation of 5-LO by stress stimuli was transient, and maximal 5-LO activity was obtained when the stimuli were added simultaneously with ionophore and AA (Fig. 2) . It is well documented that, dependent on the nature of the stimulus, activation of p38 MAPK is rapid and declines within minutes [45 , 46 ]. There was no absolute requirement of ionophore A23187 for 5-LO activation, because sorbitol treatment of BL41-E95-A cells in the presence of AA alone caused a four- to fivefold increase in 5-LO activity versus control incubations (Fig. 1B) . In agreement with others [23 , 26 ], 5-LO product formation in BL41-E95-A cells depended on the presence of exogenous substrate and correlated to the AA concentrations. In the absence of exogenous AA, LT synthesis was not detectable under any circumstances, probably because these B cells failed to release AA from endogenous pools [47 ]. However, the concentration of AA had no substantial effect on the degree of up-regulation of 5-LO activity by cell stress.

The effects of calcium ionophore A23187, the "standard stimulus" for cellular LT formation, on kinase activation in BL41-E95-A cells and MM6 cells were actually quite different (Fig. 3C) . In MM6 cells, ionophore activated MK2 (probably also MK3), and ionophore is a potent stimulus for LT biosynthesis [13 , 39 ]. In contrast, ionophore neither activated p38 MAPK (Fig. 4A) nor stimulated p38 MAPK-dependent kinase activities of BL41-E95-A cells (Fig. 3B 3C) , and ionophore together with exogenous AA gave only marginal 5-LO activity. However, when different p38 MAPK activators were given to BL41-E95-A cells together with ionophore and AA, both the cellular 5-LO activity (Table 1 and Fig. 1 ) and kinase activity increased considerably (Fig. 3B 3C ; Fig. 4A 4B ), and the appearance of phosphorylated (active) p38 MAPK correlated with the up-regulation of 5-LO activity (Fig. 4) . Both cellular 5-LO activity (Fig. 5) and MK activation (Fig. 3C) were suppressed by the p38 MAPK inhibitor SB203580 at comparable concentrations. Although this compound at low doses (<3 µM) is assumed to be a highly specific inhibitor for p38 MAPK, it was recently shown that higher concentrations of SB203580 (3–5 µM) can also reduce phosphatidylinositol 3-kinase (PI 3-kinase)-regulated protein kinase B (PKB) activity [48 ], a kinase pathway that is also activated by oxidative stress and heat shock. In fact, similar concentrations of SB203580 were necessary for inhibition of 5-LO activity (Fig. 5) . However, PKB was inactivated by osmotic shock [49 ], and the PI 3-kinase inhibitor wortmannin (<=1 µM) failed to reduce 5-LO activity in BL41-E95-A cells (data not shown); thus the PI 3-kinase/PKB pathway is probably not involved in 5-LO activation. It thus appears that activation of p38 MAPK-regulated MKs and subsequent 5-LO phosphorylation correlate with cellular 5-LO activity in BL41-E95-A cells.

BL41-E95-A is the third cell type for which increased activity of MKs seems to correlate with increased 5-LO activity, which has also been found previously for human PMNLs and the monocytic cell line MM6. Thus, MK2 in PMNL and MM6 cells could phosphorylate 5-LO in vitro, and it seems that MK3 is also a 5-LO kinase candidate [13 ]. In-gel kinase analysis of total lysates from BL41-E95-A cells indicated that MK2 (47 and 55 kDa) is also a 5-LO kinase in these cells, but MK3 activity (40 kDa) was not detected. The 55-kDa band seemed to contain other kinases as well, as observed previously for samples from MM6 cells [13 ]. For PMNL and MM6 cells, activation of kinases which can phosphorylate 5-LO is always accompanied by increased translocation of 5-LO to the nucleus [39 ]. It has been reported that 5-LO in the Burkitt lymphoma B cell line BL41-E95-A, as well as in B-CLL cells, is associated with the nucleus [26 ]. However, by Western blot analysis of subcellular fractions (after cell lysis with NP-40), we were unable to detect 5-LO in nuclear fractions from BL41-E95-A cells, after treatment with kinase stimuli together with ionophore and exogenous arachidonate (Fig. 6) . Although we can not strictly exclude that NP-40 lysis might detach 5-LO from the nuclear membrane of BL41-E95-A cells, this might indicate that LT biosynthesis in these cells (in the presence of exogenous arachidonate) could occur in a nonnuclear compartment. For eosinophils it was published that 5-LO is present also in cytoplasmic lipid bodies [50 ], and lipid bodies in U937 cells contain MAPKs [51 ]. FLAP is expressed in BL41-E95-A cells [23 ], and membrane-bound FLAP (abundant in the nuclear membrane) is thought to donate AA to 5-LO during LT synthesis at the nuclear membrane [5 ]. MK886, which binds to FLAP, suppresses ionophore-induced 5-LO product formation in B cells treated with oxidative stress (diamide) at low concentration of AA (1–2.5 µM), whereas higher AA concentrations abolish the inhibitory action of this drug [26 ]. Also in our hands, MK886 (0.1–1 µM) only moderately suppressed 5-LO product formation induced by ionophore and sorbitol at 10 or 40 µmM AA (data not shown). As previously discussed [39 ], it appears that also in BL41-E95-A cells, non-nuclear 5-LO can be active in the presence of exogenous AA.

Similarities between cytosolic phospholipase A (cPLA) 2 and 5-LO suggest how phosphorylation could regulate 5-LO activity. A C2 domain in cPLA;I2 mediates Ca2+ stimulation of activity (see ref. 52 and references therein), and similar findings have been made for 5-LO [2 ]. Both enzymes also can be phosphorylated by MAPKs. For cPLA2, it has been suggested that the C2 domain, together with another phosphorylated part of the protein, could determine membrane association and thus activity [52 ]. Similar mechanisms might apply to 5-LO. In summary, we show that in BL41-E95-A cells, activation of the p38 MAPK pathway is required for efficient LT synthesis, which implies a new role for this MAPK in B cells. As discussed above, selenium-dependent peroxidases are potent determinants of 5-LO activity in lymphocytes, and the redox status is coupled to the activity of tyrosine kinases. Thus, treatment of BL41-E95-A cells with pro-oxidative agents could stimulate 5-LO in two ways, by promoting formation of the ferric form of the lipoxygenase active site and by promotion of phosphorylation of 5-LO.


arrow
ACKNOWLEDGEMENTS
 
This study was supported by grants from the Swedish Medical Research Council (03X-217), from the European Union, and from the Verum Foundation. O.W. received a Karolinska Institute Guest Scientist fellowship. We thank Dr. Dieter Steinhilber for helpful discussions, and Agneta Nordberg and Astrid Neuss for expert technical assistance.

Received January 22, 2001; revised May 9, 2001; accepted May 11, 2001.


arrow
REFERENCES
 
    1
  1. Samuelsson, B., Dahlén, S.-E., Lindgren, J.-Å., Rouzer, C. A., Serhan, C. N. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects Science 237,1171-1176[Abstract/Free Full Text]
  2. 2
  3. Hammarberg, T., Provost, P., Persson, B., Radmark, O. (2000) The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity J. Biol. Chem. 275,38787-38793[Abstract/Free Full Text]
  4. 3
  5. Chen, X. S., Funk, C. D. (2001) The N-terminal "ß-barrel" domain of 5-lipoxygenase is essential for nuclear membrane translocation J. Biol. Chem. 276,811-818[Abstract/Free Full Text]
  6. 4
  7. Radmark, O. P. (2000) The molecular biology and regulation of 5-lipoxygenase Am. J. Resp. Crit. Care Med. 161,S11-S15[Free Full Text]
  8. 5
  9. Peters-Golden, M., Brock, T. G. (2000) Intracellular compartmentalization of leukotriene biosynthesis Am. J. Resp. Crit. Care Med. 161,S36-S40[Free Full Text]
  10. 6
  11. Su, B., Karin, M. (1996) Mitogen-activated protein kinase cascades and regulation of gene expression Curr. Opin. Immunol. 8,402-411[Medline]
  12. 7
  13. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., Davis, R. J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine J. Biol. Chem. 270,7420-7426[Abstract/Free Full Text]
  14. 8
  15. New, L., Jiang, Y., Zhao, M., Liu, K., Zhu, W., Flood, L. J., Kato, Y., Parry, G. C., Han, J. (1998) PRAK, a novel protein kinase regulated by the p38 MAP kinase EMBO J 17,3372-3384[Medline]
  16. 9
  17. McLaughlin, M. M., Kumar, S., McDonnell, P. C., Van Horn, S., Lee, J. C., Livi, G. P., Young, P. R. (1996) Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase J. Biol. Chem. 271,8488-8492[Abstract/Free Full Text]
  18. 10
  19. Waskiewicz, A. J., Flynn, A., Proud, C. G., Cooper, J. A. (1997) Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2 EMBO J 16,1909-1920[Medline]
  20. 11
  21. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T., Nebreda, A. R. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins Cell 78,1027-1037[Medline]
  22. 12
  23. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., Lee, J. C. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 FEBS Lett 364,229-233[Medline]
  24. 13
  25. Werz, O., Klemm, J., Samuelsson, B., Radmark, O. (2000) 5-Lipoxygenase is phosphorylated by p38 kinase dependent MAPKAP kinases Proc. Natl. Acad. Sci. USA 97,5261-5266[Abstract/Free Full Text]
  26. 14
  27. Lepley, R. A., Muskardin, D. T., Fitzpatrick, F. A. (1996) Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase J. Biol. Chem. 271,6179-6184[Abstract/Free Full Text]
  28. 15
  29. Borsch-Haubold, A. G., Bartoli, F., Asselin, J., Dudler, T., Kramer, R. M., Apitz-Castro, R., Watson, S. P., Gelb, M. H. (1998) Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells J. Biol. Chem 273,4449-4458[Abstract/Free Full Text]
  30. 16
  31. Buschbeck, M., Ghomashchi, F., Gelb, M. H., Watson, S. P., Borsch-Haubold, A. G. (1999) Stress stimuli increase calcium-induced arachidonic acid release through phosphorylation of cytosolic phospholipase A2 Biochem. J. 344(2),359-366
  32. 17
  33. Yamaoka, K. A., Claesson, H. E., Rosen, A. (1989) Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytes J. Immunol. 143,1996-2000[Abstract]
  34. 18
  35. Yamaoka, K. A., Dugas, B., Paul-Eugene, N., Mencia-Huerta, J. M., Braquet, P., Kolb, J. P. (1994) Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes Cell. Immunol. 156,124-134[Medline]
  36. 19
  37. Irvin, C. G., Tu, Y. P., Sheller, J. R., Funk, C. D. (1997) 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice Am. J. Physiol. 16,L1053-L1058
  38. 20
  39. Spanbroek, R., Stark, H. J., JanssenTimmen, U., Kraft, S., Hildner, M., Andl, T., Bosch, F. X., Fusenig, N. E., Bieber, T., Radmark, O., Samuelsson, B., Habenicht, A. J. R. (1998) 5-Lipoxygenase expression in Langerhans cells of normal human epidermis Proc. Natl. Acad. Sci. USA 95,663-668[Abstract/Free Full Text]
  40. 21
  41. Spanbroek, R., Hildner, M., Steinhilber, D., Fusenig, N., Yoneda, K., Rådmark, O., Samuelsson, B., Habenicht, A. J. R. (2000) 5-Lipoxygenase expression in dendritic cells generated from CD34+ hematopoietic progenitors and in lymphoid organs Blood 96,3857-3865[Abstract/Free Full Text]
  42. 22
  43. Robbiani, D. F., Finch, R. A., Jäger, D., Muller, W. A., Sartorelli, A. C., Randolph, G. J. (2000) The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3ß, ELC)-dependent mobilization of dendritic cells to lymph nodes Cell 103,757-768[Medline]
  44. 23
  45. Jakobsson, P. J., Steinhilber, D., Odlander, B., Radmark, O., Claesson, H. E., Samuelsson, B. (1992) On the expression and regulation of 5-lipoxygenase in human lymphocytes Proc. Natl. Acad. Sci. USA 89,3521-3525[Abstract/Free Full Text]
  46. 24
  47. Werz, O., Steinhilber, D. (1996) Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells—the presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells Eur. J. Biochem. 242,90-97[Medline]
  48. 25
  49. Werz, O., Szellas, D., Steinhilber, D. (2000) Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a B-lymphocytic cell line Eur. J. Biochem. 267,1263-1269[Medline]
  50. 26
  51. Jakobsson, P. J., Shaskin, P., Larsson, P., Feltenmark, S., Odlander, B., Aguilarsantelises, M., Jondal, M., Biberfeld, P., Claesson, H. E. (1995) Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes Eur. J. Biochem. 232,37-46[Medline]
  52. 27
  53. Suzuki, Y., Ohsugi, K., Ono, Y. (1996) Oxidative stress triggers tyrosine phosphorylation in B cells through a redox- and inflammatory cytokine-sensitive mechanism Immunology 87,396-401[Medline]
  54. 28
  55. Lander, H. M., Levine, D. M., Novogrodsky, A. (1992) Stress stimuli-induced lymphocyte activation Cell Immunol 145,146-155[Medline]
  56. 29
  57. Bauskin, A. R., Alkalay, I., Ben-Neriah, Y. (1991) Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum Cell 66,685-696[Medline]
  58. 30
  59. Schieven, G. L., Kirihara, J. M., Myers, D. E., Ledbetter, J. A., Uckun, F. M. (1993) Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes Blood 82,1212-1220[Abstract/Free Full Text]
  60. 31
  61. Schieven, G. L., Kirihara, J. M., Burg, D. L., Geahlen, R. L., Ledbetter, J. A. (1993) p72syk tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+ signals J. Biol. Chem. 268,16688-16692[Abstract/Free Full Text]
  62. 32
  63. Craxton, A., Shu, G., Graves, J. D., Saklatvala, J., Krebs, E. G., Clark, E. A. (1998) p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes J. Immunol. 161,3225-3236[Abstract/Free Full Text]
  64. 33
  65. Graves, J. D., Draves, K. E., Craxton, A., Saklatvala, J., Krebs, E. G., Clark, E. A. (1996) Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes Proc. Natl. Acad. Sci. USA 93,13814-13818[Abstract/Free Full Text]
  66. 34
  67. Hammarberg, T., Radmark, O. (1999) 5-Lipoxygenase binds calcium Biochemistry 38,4441-4447[Medline]
  68. 35
  69. Werz, O., Brungs, M., Steinhilber, D. (1996) Purification of transforming growth factor beta1 from human platelets Pharmazie 51,893-896[Medline]
  70. 36
  71. Brungs, M., Radmark, O., Samuelsson, B., Steinhilber, D. (1995) Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D-3 Proc. Natl. Acad. Sci. USA 92,107-111[Abstract/Free Full Text]
  72. 37
  73. Steinhilber, D., Herrmann, T., Roth, H. J. (1989) Separation of lipoxins and leukotrienes from human granulocytes by high-performance liquid chromatography with a Radial-Pak cartridge after extraction with an octadecyl reversed-phase column J. Chromatogr. 493,361-366[Medline]
  74. 38
  75. Hammarberg, T., Zhang, Y. Y., Lind, B., Radmark, O., Samuelsson, B. (1995) Mutations at the C-terminal isoleucine and other potential iron ligands of 5-lipoxygenase Eur. J. Biochem. 230,401-407[Medline]
  76. 39
  77. Werz, O., Klemm, J., Samuelsson, B., Radmark, O. (2001) Phorbol ester upregulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human PMNL Blood 97,2487-2495[Abstract/Free Full Text]
  78. 40
  79. Hecht, D., Zick, Y. (1992) Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro Biochem. Biophys. Res. Commun. 188,773-779[Medline]
  80. 41
  81. Percival, M. D., Denis, D., Riendeau, D., Gresser, M. J. (1992) Investigation of the mechanism of nonturnover-dependent inactivation of purified human 5-lipoxygenase—inactivation by H2O2 and inhibition by metal ions Eur. J. Biochem. 210,109-117[Medline]
  82. 42
  83. Stokoe, D., Engel, K., Campbell, D. G., Cohen, P., Gaestel, M. (1992) Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins FEBS Lett 313,307-313[Medline]
  84. 43
  85. Jakobsson, P. J., Odlander, B., Steinhilber, D., Rosen, A., Claesson, H. E. (1991) Human lymphocytes-B possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene-B4 Biochem. Biophys. Res. Commun. 178,302-308[Medline]
  86. 44
  87. Sutherland, C. L., Heath, A. W., Pelech, S. L., Young, P. R., Gold, M. R. (1996) Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor J. Immunol. 157,3381-3390[Abstract]
  88. 45
  89. Hannigan, M., Zhan, L., Ai, Y., Huang, C. K. (1998) The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils Biochem. Biophys. Res. Commun. 246,55-58[Medline]
  90. 46
  91. Krump, E., Sanghera, J. S., Pelech, S. L., Furuya, W., Grinstein, S. (1997) Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils J. Biol. Chem. 272,937-944[Abstract/Free Full Text]
  92. 47
  93. Larsson, P. K. A., Claesson, H. E., Kennedy, B. P. (1998) Multiple splice variants of the human calcium-independent phospholipase A(2) and their effect on enzyme activity J. Biol. Chem. 273,207-214[Abstract/Free Full Text]
  94. 48
  95. Lali, F. V., Hunt, A. E., Turner, S. J., Foxwell, B. M. (2000) The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase J. Biol. Chem. 275,7395-7402[Abstract/Free Full Text]
  96. 49
  97. Meier, R., Thelen, M., Hemmings, B. A. (1998) Inactivation and dephosphorylation of protein kinase Balpha (PKBalpha) promoted by hyperosmotic stress EMBO J 17,7294-7303[Medline]
  98. 50
  99. Bozza, P. T., Yu, W. G., Cassara, J., Weller, P. F. (1998) Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects J. Leukoc. Biol. 64,563-569[Abstract]
  100. 51
  101. Yu, W. G., Bozza, P. T., Tzizik, D. M., Gray, J. P., Cassara, J., Dvorak, A. M., Weller, P. F. (1998) Co-compartmentalization of MAP kinases and cytosolic phospholipase A(2) at cytoplasmic arachidonate-rich lipid bodies Am. J. Pathol. 152,759-769[Abstract]
  102. 52
  103. Gijon, M. A., Spencer, D. M., Kaiser, A. L., Leslie, C. C. (1999) Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2 J. Cell Biol. 145,1219-1232[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen
Physiology of Cell Volume Regulation in Vertebrates
Physiol Rev, January 1, 2009; 89(1): 193 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. O. Barnstein, G. Li, Z. Wang, S. Kennedy, C. Chalfant, H. Nakajima, K. D. Bunting, and J. J. Ryan
Stat5 Expression Is Required for IgE-Mediated Mast Cell Function.
J. Immunol., September 1, 2006; 177(5): 3421 - 3426.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Rakonjac, L. Fischer, P. Provost, O. Werz, D. Steinhilber, B. Samuelsson, and O. Radmark
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production
PNAS, August 29, 2006; 103(35): 13150 - 13155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Liu, P. Zhu, and B. D. Freedman
Multiple eicosanoid-activated nonselective cation channels regulate B-lymphocyte adhesion to integrin ligands
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C873 - C882.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Runarsson, A. Liu, Y. Mahshid, S. Feltenmark, A. Pettersson, E. Klein, M. Bjorkholm, and H.-E. Claesson
Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells
Blood, February 1, 2005; 105(3): 1274 - 1279.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Guan, J.-H. Kim, S. Lomvardas, K. Holick, S. Xu, E. R. Kandel, and J. H. Schwartz
p38 MAP Kinase Mediates Both Short-Term and Long-Term Synaptic Depression in Aplysia
J. Neurosci., August 13, 2003; 23(19): 7317 - 7325.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Radmark
5-Lipoxygenase-Derived Leukotrienes: Mediators Also of Atherosclerotic Inflammation
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(7): 1140 - 1142.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Burkert, D. Szellas, O. Radmark, D. Steinhilber, and O. Werz
Cell type-dependent activation of 5-lipoxygenase by arachidonic acid
J. Leukoc. Biol., January 1, 2003; 73(1): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Werz, D. Szellas, D. Steinhilber, and O. Radmark
Arachidonic Acid Promotes Phosphorylation of 5-Lipoxygenase at Ser-271 by MAPK-activated Protein Kinase 2 (MK2)
J. Biol. Chem., April 19, 2002; 277(17): 14793 - 14800.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Burkert, O. Radmark, B. Samuelsson, D. Steinhilber, and O. Werz
Hypertonicity suppresses ionophore-induced product formation and translocation of 5-lipoxygenase in human leukocytes
J. Leukoc. Biol., March 1, 2002; 71(3): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Werz, E. Burkert, B. Samuelsson, O. Radmark, and D. Steinhilber
Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes
Blood, February 1, 2002; 99(3): 1044 - 1052.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werz, O.
Right arrow Articles by Samuelsson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werz, O.
Right arrow Articles by Samuelsson, B.